Skip to content
10-K

Annual Report

THC THERAPEUTICS, INC.

0001477932-26-001083

← back to feed
Filed
Feb 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 10, 2026 40.27M sh
Operating Cash Flow FY 2024 · Jul 31, 2024 −$183.27K
Operating Cash Flow FY 2024 · Jul 31, 2023 −$85.43K
Cash And Equivalents FY 2024 · Jul 31, 2024 $35
Cash And Equivalents FY 2024 · Jul 31, 2023 $10
Stockholders Equity FY 2024 · Jul 31, 2024 −$3.8M
Stockholders Equity FY 2024 · Jul 31, 2023 −$3.31M
Stockholders Equity FY 2024 · Jul 31, 2022 −$3.11M
Current Liabilities FY 2024 · Jul 31, 2024 $3.81M
Current Liabilities restated FY 2024 · Jul 31, 2023 $3.32M
Total Liabilities FY 2024 · Jul 31, 2024 $3.81M
Total Liabilities restated FY 2024 · Jul 31, 2023 $3.32M
Current Assets FY 2024 · Jul 31, 2024 $35
Current Assets FY 2024 · Jul 31, 2023 $980
Total Assets FY 2024 · Jul 31, 2024 $10.65K
Total Assets FY 2024 · Jul 31, 2023 $12.99K
Eps Basic FY 2024 · Jul 31, 2024 −$0.02
Eps Basic FY 2024 · Jul 31, 2023 −$0.01
Net Income FY 2024 · Jul 31, 2024 −$811.56K
Net Income FY 2024 · Jul 31, 2023 −$387.04K
Operating Income FY 2024 · Jul 31, 2024 −$541.98K
Operating Income FY 2024 · Jul 31, 2023 −$493.91K
Gross Profit FY 2024 · Jul 31, 2024 $0
Gross Profit FY 2024 · Jul 31, 2023 $0
Cost Of Revenue FY 2024 · Jul 31, 2024 $0
Cost Of Revenue FY 2024 · Jul 31, 2023 $0
Revenue FY 2024 · Jul 31, 2024 $0
Revenue FY 2024 · Jul 31, 2023 $0